Fig. 3From: Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus)The probability of target attainment (PTA) of cefquinome treated with the current clinical dose regimen (2 mg/kg/24 h) against E. coli at each MIC valueBack to article page